Health
Why some analysts are wary about Moderna’s Covid-19 vaccine data – IG Bank
Although Moderna’s share price has soared over 200% this year, some analysts believe the company has to deliver more substantial positive Covid-19 vaccine data in order to justify its ‘lofty’ valuation.
Shares of Moderna Inc hit a two-month peak on Wednesday 15 July 2020, following the release of more detailed Covid-19 vaccine trial data that some experts have deemed as promising.
The US pharmaceutical companys stocks hit US$84.75 per share on Wednesday morning its highest price since 19 May 2020, based on IG data. The stock was the second most traded share of the day on the IG platform.
Moderna eventually closed the session just slightly under at US$80.30 a share.
IG market analysis show th…
Continue Reading